Your browser doesn't support javascript.
loading
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Blanchet, Benoit; Xu-Vuilard, Alexandre; Jouinot, Anne; Puisset, Florent; Combarel, David; Huillard, Olivier; Le Louedec, Félicien; Thomas, Fabienne; Teixeira, Marcus; Flippot, Ronan; Mourey, Loic; Albiges, Laurence; Pudlarz, Thomas; Joly, Charlotte; Tournigand, Christophe; Chauvin, Jonathan; Puszkiel, Alicja; Chatelut, Etienne; Decleves, Xavier; Vidal, Michel; Goldwasser, François; Oudard, Stéphane; Medioni, Jacques; Vano, Yann-Alexandre.
Affiliation
  • Blanchet B; Université de Paris, CNRS, INSERM, CiTCoM, U1268, F-75006, Paris, France. benoit.blanchet@aphp.fr.
  • Xu-Vuilard A; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France. benoit.blanchet@aphp.fr.
  • Jouinot A; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France. benoit.blanchet@aphp.fr.
  • Puisset F; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France.
  • Combarel D; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  • Huillard O; Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, Paris, France.
  • Le Louedec F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.
  • Thomas F; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.
  • Teixeira M; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.
  • Flippot R; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Mourey L; Faculté de pharmacie, Université Paris Saclay, Orsay, France.
  • Albiges L; Medical School, University of Paris XI, Saclay, France.
  • Pudlarz T; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.
  • Joly C; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.
  • Tournigand C; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.
  • Chauvin J; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.
  • Puszkiel A; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.
  • Chatelut E; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037, Toulouse, France.
  • Decleves X; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.
  • Vidal M; Medical School, University of Paris XI Saclay, Saclay, France.
  • Goldwasser F; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.
  • Oudard S; Medical School, University of Paris XI Saclay, Saclay, France.
  • Medioni J; Laboratoire d'immunomonitoring en oncologie, CNRS3655 & INSERM US23, Université Paris Saclay, Paris, France.
  • Vano YA; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.
Br J Cancer ; 130(6): 961-969, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38272963

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2024 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2024 Document type: Article Affiliation country: Francia Country of publication: Reino Unido